PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Medical University of Lublin, Lublin, Poland.\', \'Department of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2174/1570159X19666210729123734
?:hasPublicationType
?:journal
  • Current neuropharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34325642
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.21
?:rankingScore_hIndex
  • 53
?:title
  • Fluvoxamine and Amantadine: Central Nervous System Acting Drugs Repositioned for COVID-19 as Early Intervention.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all